A0A6D2Y9A4 (A0A6D2Y9A4_PANTR) Pan troglodytes (Chimpanzee)

ELOB isoform 1 UniProtKBInterProInteractive Modelling

118 aa; Sequence (Fasta) ; 9 identical sequences: Homo sapiens: Q15370; Pongo abelii: A0A2J8S830; Pan troglodytes: K7BP33; Papio anubis: A0A096NL81; Macaca mulatta: I2CTS0; Macaca fascicularis: A0A2K5UJD0; Rhinopithecus bieti: A0AAJ7MHC9, A0A2K6KJ09; Piliocolobus tephrosceles: A0A8C9I8I0

Available Structures

168 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
SOCS box elonginBC ternary complex Heteromer
O35718; P83940; Q15370;
1-118
100
HIV-1 Vif SOCS-box and Elongin BC solution structure Heteromer
P12504; Q15369; Q15370;
1-118
100
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P40337; P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-118
100
Crystal structure of VHL in complex with H313, a Helicon Polypeptide Heteromer
P40337; Q15369; Q15370;
1-108
100WHL;
Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex Heteromer
P40337; Q15369; Q15370; Q16665;
1-106
100
Crystal structure of HIF-2alpha-pVHL-elongin B-elongin C Heteromer
P40337; Q15369; Q15370; Q99814;
1-106
100
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q03071; Q13098; Q13617; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-106
100ZN;
Structure of CRL2APPBP2 bound with the C-degron of MRPL28 (dimer) Heteromer
Q13617; Q15369; Q15370; Q92624;
1-106
100ZN;
von Hippel-Lindau protein-ElonginB-ElonginC complex, bound to Hif1- alpha peptide Heteromer
P40337; Q15369; Q15370; Q16665;
1-105
100GOL;
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
P40337; Q15369; Q15370; Q16665;
1-105
100SO4;F4K;GOL;
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
P40337; Q15370; Q2KII4; Q99814;
1-105
100GOL;
PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL Heteromer
P40337; Q07817; Q15369; Q15370;
1-105
100QL8; 17×EDO;GOL; 12×IOD;
FAK Protac GSK215 in complex with FAK and pVHL:ElonginC:ElonginB Heteromer
P40337; Q05397; Q15369; Q15370;
1-105
1007QB;PEG; 14×EDO;CA;
Ternary complex of VHL/BRD4-BD1/Compound9 (4-(3,5-difluoropyridin-2-yl)-N-(11-(((S)-1-((2S,4R)-4-hy… Heteromer
O60885; P40337; Q15369; Q15370;
1-105
100WEP;
CRYSTAL STRUCTURE OF SOCS-4 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 2.55A RESOLUTION Heteromer
Q15369; Q15370; Q8WXH5;
1-105
100NA;EDO;CL;
E3:PROTAC:target ternary complex structure (VCB/753b/BCL-2) Heteromer
P10415; P40337; Q15369; Q15370;
1-105
100YF8;
VHL recognizes hydroxyproline in RIPK1 Heteromer
P40337; Q13546; Q15369; Q15370;
1-105
98.09
pVHL-EloB-EloB-EloC complex_(2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidany… Heteromer
P40337; Q15369; Q15370;
1-105
100ACT;UCK;
E3:PROTAC:target ternary complex structure (VCB/753b/BCL-xL) Heteromer
P40337; Q07817; Q15369; Q15370;
1-105
100CAD;GOL;YF8;
E3:PROTAC:target ternary complex structure (VCB/WH244/BCL-2) Heteromer
P10415; P40337; Q15369; Q15370;
1-105
100YFH;
Ankyrin repeat and SOCS-box protein 9 (ASB9), ElonginB (ELOB), and ElonginC (ELOC) bound to its sub… Heteromer
P12277; Q15369; Q15370; Q96DX5;
2-106
100
Ubiquitin ligation to neosubstrate by a cullin-RING E3 ligase & Cdc34: NEDD8-CUL2-RBX1-ELOB/C-VHL-M… Heteromer
O60885; P0CG48; P40337; P62877; Q13617; Q15369; Q15370; Q712K3;
1-105
100ZN;SY8;759;
Structure of CRL2APPBP2 bound with the C-degron of MRPL28 (tetramer) Heteromer
P62877; Q13084; Q13617; Q15369; Q15370; Q92624;
2-106
100.0ZN;
Structure of CRL2APPBP2 bound with RxxGP degron (tetramer) Heteromer
P62877; Q13617; Q15369; Q15370; Q92624;
2-106
100.0ZN;
Structure of CRL2APPBP2 bound with RxxGPAA degron (tetramer) Heteromer
P62877; Q13617; Q15369; Q15370; Q92624;
2-106
100.0ZN;
Structure of CRL2APPBP2 bound with RxxGP degron (dimer) Heteromer
Q13617; Q15369; Q15370; Q92624;
2-106
100ZN;
Structure of CRL2APPBP2 bound with RxxGPAA degron (dimer) Heteromer
Q13617; Q15369; Q15370; Q92624;
2-106
100ZN;
Crystal structure of compound 10 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
100IOD;IFJ;
Ternary complex between VCB, BRD4-BD1 and PROTAC 48 Heteromer
O60885; P40337; Q15369; Q15370;
1-104
100SO4;EDO;QIY;
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:El… Heteromer
P40337; P51532; Q15369; Q15370;
1-104
100FWZ;DMS;
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound MN551 Heteromer
O14508; Q15369; Q15370;
1-104
100JIH;
pVHL:EloB:EloC in complex with modified HIF-1a CODD peptide containing (3R,4S)-3-fluoro-4-hydroxypr… Heteromer
P40337; Q15369; Q15370; Q16665;
1-104
100
co-crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 13 Heteromer
O14508; Q15369; Q15370;
1-104
100EDO;JH9;
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 9 Heteromer
O14508; Q15369; Q15370;
1-104
100JHR;PO4;
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
P40337; Q15369; Q15370; Q99814;
1-104
100FMT;
Crystal structure of compound 6 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
100IFF;
Crystal structure of the VCB complex with compound 1. Heteromer
P40337; Q15369; Q15370;
1-104
100WBN;CL;
Crystal structure of the complex between VHL, ElonginB, ElonginC, and compound 5 Heteromer
P40337; Q15369; Q15370;
1-104
100EDO;DMS;CL;A1ARP;
pVHL-ELOB-ELOC complex_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)ben… Heteromer
P40337; Q15369; Q15370;
1-104
100.0TG0;
Crystal structure of a hydroxylated HIF-1 alpha peptide bound to the pVHL/elongin-C/elongin-B compl… Heteromer
P40337; Q15369; Q15370; Q16665;
1-104
100SO4;
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 13 Heteromer
O14508; Q15369; Q15370;
1-104
100JH9;
VCB in complex with compound 30 Heteromer
P40337; Q15369; Q15370;
1-104
100QE0;
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #2) Heteromer
P40337; P61964; Q15369; Q15370;
1-104
100SCN;Q3X;EDO;
Crystal structure of pVHL:EloB:EloC in complex with MP-1-39 Heteromer
P40337; Q15369; Q15370;
1-104
100.0A1H6O;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hy… Heteromer
P40337; Q15369; Q15370;
1-104
1009BH;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-y… Heteromer
P40337; Q15369; Q15370;
1-104
1003JU;
pVHL:EloB:EloC in complex with (2S,4R)-4-hydroxy-1-((S)-2-(2-hydroxyacetamido)-3,3-dimethylbutanoyl… Heteromer
P40337; Q15369; Q15370;
1-104
1009BT;
VCB in complex with compound 32 Heteromer
P40337; Q15369; Q15370;
1-104
100QF7;
Crystal structure of pVHL:EloB:EloC in complex with MP-1-21 Heteromer
P40337; Q15369; Q15370;
1-104
100A1H9F;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-3,3-dimethyl-2-(oxetane-3-carboxamido)butanoyl)-4-hyd… Heteromer
P40337; Q15369; Q15370;
1-104
1009B8;
Crystal Structure of compound 3 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB Heteromer
P01116; P40337; Q15369; Q15370;
1-104
100GDP;X4R;MG;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-h… Heteromer
P40337; Q15369; Q15370;
1-104
1009BW;
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker Heteromer
P40337; P61964; Q15369; Q15370;
1-104
10010×SCN;Q43;EDO;K;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-fluorocyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
P40337; Q15369; Q15370;
1-104
1004YY;
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 12 Heteromer
O14508; Q15369; Q15370;
1-104
100.0JI0;
Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
100FX8; 11×EDO;FMT;
Crystal structure of PROTAC 5 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
100IEI;
Crystal Structure of ligand ACBi1 in complex with bromodomain of human Smarca2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
100EDO;NA;PEG;87A;
VCB in complex with compound 27 Heteromer
P40337; Q15369; Q15370;
1-104
100QF3;
pVHL:EloB:EloC in complex with modified VH032 containing (3S,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
P40337; Q15369; Q15370;
1-104
100EXE;
Crystal structure of pVHL:ElonginC:ElonginB complex bound to PROTAC JW48 Heteromer
P40337; Q15369; Q15370;
1-104
100SYF;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetamidocyclopropanecarboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370;
1-104
1009BK;
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methy… Heteromer
P40337; Q15369; Q15370;
1-104
100QD0;
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
100EDO;FWZ;EPE;
Crystal Structure of compound 4 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB Heteromer
P01116; P40337; Q15369; Q15370;
1-104
100.0X53;GDP;MG;
pVHL:EloB:EloC in complex with (2S,4R)-N-((S)-1-(5-Fluoro-2-methoxy-4-(4-methylthiazol-5-yl)phenyl)… Heteromer
P40337; Q15369; Q15370;
1-104
100VH3;
pVHL:EloB:EloC in complex with VH298 Heteromer
P40337; Q15369; Q15370;
1-104
1006Z3;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthi… Heteromer
P40337; Q15369; Q15370;
1-104
100DV5;
Crystal structure of the complex between VHL, ElonginB, ElonginC, and compound 5 Heteromer
P40337; Q15369; Q15370;
1-104
100TFA;PEG;EDO;ACT;
Crystal structure of EloBC-VHL-CDO1 complex bound to compound 8 molecular glue Heteromer
P40337; Q15369; Q15370; Q16878;
1-104
100A1ACI;CIT;FE2;
Crystal Structure of Ankyrin Repeat and Socs Box-Containing Protein 9 (Asb9) in Complex with Elongi… Heteromer
Q15369; Q15370; Q96DX5;
2-105
100.0EDO;PEG;CL;
Crystal structure of SOCS2:ElonginB:ElonginC in complex with compound 11 Heteromer
O14508; Q15369; Q15370;
1-104
100.0JI9;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370;
1-104
100VYQ;
pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisox… Heteromer
P40337; Q15369; Q15370;
1-104
100.0TR0;
Ternary complex between VCB, BRD4-BD2 and PROTAC 51 Heteromer
O60885; P40337; Q15369; Q15370;
1-104
100QLX;
The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB Heteromer
O60885; P40337; Q15369; Q15370;
1-104
100759;
pVHL:EloB:EloC in complex with modified VH032 containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
P40337; Q15369; Q15370;
1-104
100EXH;
Co-crystal structure of Compound 11 in complex with the bromodomain of human SMARCA2 and pVHL:Elong… Heteromer
P40337; P51531; Q15369; Q15370;
1-104
100GOL;FWZ;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
P40337; Q15369; Q15370;
1-104
1009BN;
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
P40337; Q15369; Q15370;
1-104
100DV8;
VCB in complex with compound 23 Heteromer
P40337; Q15369; Q15370;
1-104
100QFR;
VCB in complex with compound 21 Heteromer
P40337; Q15369; Q15370;
1-104
100.0QFF;
SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC Heteromer
P40337; Q13451; Q15369; Q15370;
1-104
100XZW;
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with C3 linker Heteromer
P40337; P61964; Q15369; Q15370;
1-104
100Q3R;
Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide Heteromer
O14508; Q15369; Q15370;
1-104
100CO;
Ankyrin repeat and SOCS-box protein 9 (ASB9) in complex with ElonginB and ElonginC Heteromer
Q15369; Q15370; Q96DX5;
2-105
100.0EDO;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbu… Heteromer
P40337; Q15369; Q15370;
1-104
100VFO;
Crystal structure of EloBC-VHL-CDO1 complex bound to compound 4 molecular glue Heteromer
P40337; Q15369; Q15370; Q16878;
1-104
1003JF;CIT;FE2;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamidopropanoyl)-4-hydroxy-N-(4-(4-methylthiazol… Heteromer
P40337; Q15369; Q15370;
1-104
1009B5;
Ternary complex between VCB, BRD4-BD2 and PROTAC 48 Heteromer
O60885; P40337; Q15369; Q15370;
1-104
100QIY;
Ternary complex between VCB, BRD4-BD1 and PROTAC 49 Heteromer
O60885; P40337; Q15369; Q15370;
1-104
100SO4;QIK;
Structure of VHL-EloB-EloC-Cul2 Heteromer
P40337; Q13617; Q15369; Q15370;
1-104
100
Crystal structure of macrocyclic PROTAC 1 in complex with the second bromodomain of human Brd4 and … Heteromer
O60885; P40337; Q15369; Q15370;
1-104
100LFE;
cGAS-Nucleosome in complex with SPSB3-ELOBC (composite structure) Heteromer
P62805; Q15369; Q15370; Q6PJ21; Q71DI3; Q8N884; Q93079; Q96KK5; Q99877; Q99878;
1-104
100ZN;
Structure of cGAS in complex with SPSB3-ELOBC Heteromer
Q15369; Q15370; Q6PJ21; Q8N884;
1-104
100ZN;
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-104
100ZN;
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-104
100
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P40337; P61201; P62877; Q03071; Q13098; Q13617; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
1-104
100ZN;
(NEDD8)-CRL2VHL-MZ1-Brd4BD2-Ub(G76S, K48C)-UBE2R1(C93K, S138C, C191S, C223S)-Ub Heteromer
O60885; P0CG48; P40337; P49427; P62877; Q13617; Q15369; Q15370; Q15843;
1-104
100.0759;ZN;
Open non-crosslinked structure Brd4BD2-MZ1-(NEDD8)-CRL2VHL Heteromer
O60885; P40337; P62877; Q13617; Q15369; Q15370;
1-104
100759;ZN;
The complex structure of Cul2-VCB-Protac-Wee1 Heteromer
P30291; P40337; P62877; Q13617; Q15369; Q15370;
1-104
100W6U;
Crystal structure of Protac MS33 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… Heteromer
P40337; P61964; Q15369; Q15370;
1-103
100SCN;EDO;VKA;GOL;NA;
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1) Heteromer
P40337; P61964; Q15369; Q15370;
1-103
10015×SCN; 13×EDO;P6G;Q3X;
CRYSTAL STRUCTURE OF SOCS-2 IN COMPLEX WITH ELONGIN-B AND ELONGIN-C AT 1.9A RESOLUTION Heteromer
O14508; Q15369; Q15370;
2-104
100SO4;NI;
pVHL:EloB:EloC in complex with methyl 4H-furo[3,2-b]pyrrole-5-carboxylate Heteromer
P40337; Q15369; Q15370;
1-103
100ACT;F4E;
Crystal structure of SOCS2:Elongin C:Elongin B in complex with growth hormone receptor peptide Heteromer
O14508; Q15369; Q15370;
1-103
100CO;
VCB in complex with compound 26 Heteromer
P40337; Q15369; Q15370;
1-103
100QE9;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamido-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-m… Heteromer
P40337; Q15369; Q15370;
1-103
1003JF;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-3,3-dimethylb… Heteromer
P40337; Q15369; Q15370;
1-103
1003JO;
Crystal structure of Protac MS67 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… Heteromer
P40337; P61964; Q15369; Q15370;
1-103
100GOL;X6M;
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-… Heteromer
P40337; Q15369; Q15370;
1-103
100X6C;ACT;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(oxazol-5-yl)benzyl)… Heteromer
P40337; Q15369; Q15370;
1-103
1003JG;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methyloxazol-5-yl… Heteromer
P40337; Q15369; Q15370;
1-103
1003JK;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-3,3-dimethylb… Heteromer
P40337; Q15369; Q15370;
1-103
1003JH;
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3,3-dimethylbutanamido)-3,3-dimeth… Heteromer
P40337; Q15369; Q15370;
1-103
1003JJ;
Crystal Structure of ligand ACBI3 in complex with KRAS G12D C118S GDP and pVHL:ElonginC:ElonginB co… Heteromer
P01116; P40337; Q15369; Q15370;
1-103
100WYL;GDP;MG;
pVHL:EloB:EloC in complex with (2S,4R)-1-((2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carbonyl)-4-hydro… Heteromer
P40337; Q15369; Q15370;
1-103
1003JS;
Quaternary Complex of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC Homer Heteromer
P40337; P61964; Q15369; Q15370;
1-103
1008KH;
pVHL:EloB:EloC complex, in complex with capped Hydroxyproline Heteromer
P40337; Q15369; Q15370;
1-103
100.0ACT;V6F;
pVHL:EloB:EloC in complex with 6-chlorothiochroman-4-one Heteromer
P40337; Q15369; Q15370;
1-103
100F7B;IPA;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(thiazol-5-yl)benzyl… Heteromer
P40337; Q15369; Q15370;
1-103
1003JT;
Crystal structure of SOCS2:Elongin C:Elongin B in complex with erythropoietin receptor peptide Heteromer
O14508; Q15369; Q15370;
1-103
100PEG;
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(3-methyl-4-(thiazol-5-… Heteromer
P40337; Q15369; Q15370;
1-103
1003JV;
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
P40337; Q15369; Q15370;
1-103
100.0
pVHL54-213-EloB-EloC complex _ methyl 4-(((2S,4R)-4-hydroxy-1-(2-(3- methylisoxazol-5-yl)acetyl)pyr… Heteromer
P40337; Q15369; Q15370;
1-103
100.0ZTD;
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
P40337; Q15369; Q15370;
1-103
100DV2;
pVHL54-213-EloB-EloC complex_apo Heteromer
P40337; Q15369; Q15370;
1-103
100.0
Structure of SOCS2:Elongin C:Elongin B from DMSO-treated crystals Heteromer
O14508; Q15369; Q15370;
2-104
100
BRG1 bromodomain in complex with VBC via compound 17 Heteromer
P40337; P51532; Q15369; Q15370;
1-103
100PO4;GOL;VLH;
VHL/Elongin B/Elongin C complex with compound 155 Heteromer
P40337; Q15369; Q15370;
1-103
100VL6;
Crystal structure of SOCS2/ElonginB/ElonginC bound to a non-canonical peptide that enhances phospho… Heteromer
O14508; Q15369; Q15370;
2-104
100SO4;
Co-crystal structure of Compound 1 in complex with the bromodomain of human SMARCA4 and pVHL:Elongi… Heteromer
P40337; P51532; Q15369; Q15370;
1-103
100.0NA;YHB;PEG;
PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1 Heteromer
P01116; P40337; P62877; Q13617; Q15369; Q15370;
2-104
100ZN;GDP;WYL;
pVHL54-213-EloB-EloC complex_(2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol- 5-yl)acetyl)-N-(4-nitrobenzy… Heteromer
P40337; Q15369; Q15370;
1-102
100GOL;ZUN;
CRYSTAL STRUCTURE OF AT7 IN COMPLEX WITH THE SECOND BROMODOMAIN OF HUMAN BRD4 AND PVHL:ELONGINC:ELO… Heteromer
O60885; P40337; Q15369; Q15370;
1-102
100.0IZR;
DNA-encoded library (DEL)-enabled discovery of proximity inducing small molecules Heteromer
O60885; P40337; Q15369; Q15370;
1-102
100X5K;
Crystal Structure of the HIV Vif BC-box in Complex with Human ElonginB and ElonginC Heteromer
P12504; Q15369; Q15370;
1-100
100.0
Crystal Structure of SOCS1 in complex with ElonginB and ElonginC Heteromer
C0LEJ4; Q00560; Q15369; Q15370;
1-100
100
Structure of KLHDC2-EloB/C tetrameric assembly Heteromer
Q15369; Q15370; Q9Y2U9;
1-99
100.0
pVHL54-213-EloB-EloC complex (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL… Heteromer
P40337; Q15369; Q15370;
1-99
100L8B;
Ubiquitin ligation to substrate by a cullin-RING E3 ligase & Cdc34: NEDD8-CUL2-RBX1-ELOB/C-FEM1C wi… Heteromer
P0CG48; P62877; Q13617; Q15369; Q15370; Q712K3; Q96JP0; Q9H173;
1-99
100U9O;ZN;
cryo-EM structure of neddylated CUL2-RBX1-ELOB-ELOC-FEM1B bound with the C-degron of CCDC89 (confor… Heteromer
P62877; Q13617; Q15369; Q15370; Q8N998; Q9UK73;
2-100
100.0ZN;
Cryo-EM structure of CUL2-RBX1-ELOB-ELOC-FEM1B bound with the C-degron of CCDC89 (conformation 1) Heteromer
P62877; Q13617; Q15369; Q15370; Q8N998; Q9UK73;
2-100
100.0ZN;
Cryo-EM structure of CUL2-RBX1-ELOB-ELOC-FEM1B bound with the C-degron of CUX1 (conformation 1) Heteromer
P62877; Q13617; Q13948; Q15369; Q15370; Q9UK73;
2-100
100.0ZN;
cryo-EM structure of CUL2-RBX1-ELOB-ELOC-FEM1B bound with the C-degron of CUX1 (conformation 2) Heteromer
P62877; Q13617; Q13948; Q15369; Q15370; Q9UK73;
2-100
100.0ZN;
Cryo-EM structure of CUL2-RBX1-ELOB-ELOC-FEM1B bound with the C-degron of CCDC89 (conformation 2) Heteromer
P62877; Q13617; Q15369; Q15370; Q8N998; Q9UK73;
2-100
100.0ZN;
THE VHL-ELONGINC-ELONGINB STRUCTURE Heteromer
P40337; Q15369; Q15370;
1-98
100
Crystal structure of SIVrcm Vif-CBFbeta-ELOB-ELOC complex Heteromer
E1ANT9; Q13951; Q15369; Q15370;
1-98
100ZN;GOL;
Crystal structure of the Vif-CBFbeta-CUL5-ElOB-ElOC pentameric complex Heteromer
P12504; Q13951; Q15369; Q15370; Q93034;
1-98
100.0ZN;
The cryo-EM structure of PPP2R5A/HIV-1 Vif/CBFb/EloB/EloC complex Heteromer
P12504; Q13951; Q15172; Q15369; Q15370;
1-98
100.0
KLHDC2 in complex with EloB and EloC Heteromer
Q15369; Q15370; Q9Y2U9;
1-98
100
Crystal structure of the Cul2-Rbx1-EloBC-VHL ubiquitin ligase complex Heteromer
P40337; P62877; Q13617; Q15369; Q15370;
1-97
100.0ZN;
Cryo-EM structure of neddylated Cul2-Rbx1-EloBC-FEM1B complexed with FNIP1-FLCN Heteromer
Q13617; Q15369; Q15370; Q8TF40; Q9UK73;
1-97
100.0ZN;
H. sapiens replisome-CUL2/LRR1 complex Heteromer
O75419; O75717; P25205; P33991; P33992; P33993; P49736; P56282; P62877; Q07864; Q13617; Q14566; Q14691; Q15369; Q15370; Q96L50; Q9BRT9; Q9BRX5; Q9BVW5; Q9HAW4; Q9UNS1; Q9Y248;
1-97
100.0ZN;MG;ANP;SO4;
K48-linked ubiquitin chain formation with a cullin-RING E3 ligase and Cdc34: NEDD8-CUL2-RBX1-ELOB/C… Heteromer
P0CG48; P62877; Q13617; Q15369; Q15370; Q712K3; Q96JP0; Q9H173;
1-97
100SY8;ZN;
An asymmetry dimer of the Cul2-Rbx1-EloBC-FEM1B ubiquitin ligase complexed with BEX2 Heteromer
P62877; Q13617; Q15369; Q15370; Q9UK73;
1-97
100.0ZN;
Protomer 1 and 2 of the asymmetry trimer of the Cul2-Rbx1-EloBC-FEM1B ubiquitin ligase complex Heteromer
P62877; Q13617; Q15369; Q15370; Q9UK73;
1-97
100.0ZN;
cryo-EM structure of neddylated CUL2-RBX1-ELOB-ELOC-FEM1B bound with the C-degron of CDK5R1 Heteromer
P62877; Q13617; Q15369; Q15370; Q15843; Q9UK73;
2-97
100.0ZN;
Maedi visna virus Vif in complex with CypA and E3 ubiquitin ligase Heteromer
P62937; P69717; Q15369; Q15370;
1-96
100.0ZN;
Human APOBEC3H bound to HIV-1 Vif in complex with CBF-beta, ELOB, ELOC, and CUL5 Heteromer
P12504; Q13951; Q15369; Q15370; Q6NTF7; Q93034;
1-96
100.0ZN;
Dimeric form of HIV-1 Vif in complex with human CBF-beta, ELOB, ELOC, and CUL5 Heteromer
P12504; Q13951; Q15369; Q15370; Q93034;
1-96
100.0ZN;
cryo-EM structure of neddylated CUL2-RBX1-ELOB-ELOC-FEM1B bound with the C-degron of CCDC89 (confor… Heteromer
P62877; Q13617; Q15369; Q15370; Q15843; Q9UK73;
2-97
100.0ZN;
Cryo-EM structure of human APOBEC3G/HIV-1 Vif/CBFbeta/ELOB/ELOC dimeric complex in State 2 Heteromer
P69723; Q13951; Q15369; Q15370; Q9HC16;
2-96
100.0ZN;
Cryo-EM structure of human APOBEC3G/HIV-1 Vif/CBFbeta/ELOB/ELOC dimeric complex in State 1 Heteromer
P69723; Q13951; Q15369; Q15370; Q9HC16;
2-96
100.0ZN;
Cryo-EM structure of human APOBEC3G/HIV-1 Vif/CBFbeta/ELOB/ELOC monomeric complex Heteromer
P69723; Q13951; Q15369; Q15370; Q9HC16;
2-96
100.0ZN;
Structure of the mammalian Pol II-Elongin complex, lacking the ELOA latch (composite structure, str… Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; Q14241; Q15369; Q15370;
1-88
100MG;ZN;
Structure of the mammalian Pol II-SPT6-Elongin complex, lacking ELOA latch (composite structure, st… Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; Q14241; Q15369; Q15370; Q7KZ85;
1-88
100MG;ZN;
Structure of the mammalian Pol II-SPT6-Elongin complex, Structure 1 Heteromer
A0A287ADR4; A0A4X1TRS6; A0A4X1VEK9; A0A4X1VKG7; A0A8D1DPV6; A0A8W4F9W9; F1RKE4; I3LCB2; I3LCH3; I3LGP4; I3LSI7; P60899; Q14241; Q15369; Q15370; Q7KZ85;
1-88
100MG;ZN;

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6gmr.1.Amonomer0.751-105
100.00